SUMMARY
Mayo Clinic researcher Adam L. Holtzman, M.D., is a radiation oncologist specializing in skull base and head and neck tumors. His research focuses on the development of highly precise radiotherapy techniques aimed at enhancing treatment effectiveness while minimizing damage to surrounding healthy tissue.
Dr. Holtzman has multiple studies enhancing disease control outcomes while simultaneously prioritizing quality of life.
Dr. Holtzman's clinical research focuses on advanced salivary gland tumors and growths in the sinonasal areas. He also studies sarcomas, chordomas and chondrosarcomas.
Focus areas
- Advanced radiotherapy. Dr. Holtzman researches advanced radiotherapy techniques. These techniques include X-ray radiotherapy and particle therapies involving protons and carbon ions. His studies enhance clinical outcomes for people with head and neck tumors and skull base tumors.
- Innovative approaches. Dr. Holtzman's research is dedicated to exploring novel radiotherapy methods to improve treatments. This research also includes treatments for rare radioresistant cancers such as chordomas, chondrosarcomas, adenoid cystic carcinomas and sinonasal malignancies.
Significance to patient care
Dr. Holtzman's research advances radiation therapy techniques to improve clinical outcomes through the pursuit of more-effective and more-precise treatments. With targeted therapies, people maintain their overall quality of life during treatment and shorten the time to recovery.
Professional highlights
- Member, Skull Base, Central Nervous System, Sarcoma Subcommittee, Particle Therapy Co-Operative Group, 2017-present.
- Member, Scanning Proton Arc Therapy Consortium, 2022-2023.
- Operations editor, International Journal of Particle Therapy, 2022-2023.
- Outstanding Resident Teacher Award, University of Florida Radiation Oncology, 2018.